Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases.
Dominika RozmusAlicja CiesielskaJanusz PłomińskiRoman GrzybowskiEwa FiedorowiczNatalia Karolina KordulewskaHuub F J SavelkoulElżbieta KostyraAnna CieślińskaPublished in: International journal of molecular sciences (2020)
Vitamin D is an important component of the endocrine system that controls calcium homeostasis and bone mineralization. Because of the very short half-life of free serum vitamin D it is stabilized and transported to target tissues by being bound to the vitamin D binding protein (VDBP). The most common polymorphisms: rs4588 and rs7041 in the vitamin D binding protein gene may correlate with differences in vitamin D status in the serum. This review presents data that relate to the presence of genetic variants in the VDBP gene in correlation with certain diseases, mostly concerning cancers (breast, prostate, pancreatic, lung, colorectal, basal cell carcinoma cancer and cutaneous melanoma) or other related diseases (thyroid autoimmunity disorders, obesity, diabetes mellitus, bone metabolism, rheumatoid arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, tuberculosis and coronary artery diseases).
Keyphrases
- binding protein
- ankylosing spondylitis
- chronic obstructive pulmonary disease
- rheumatoid arthritis
- coronary artery
- basal cell carcinoma
- prostate cancer
- disease activity
- metabolic syndrome
- bone mineral density
- insulin resistance
- genome wide
- mycobacterium tuberculosis
- type diabetes
- weight loss
- emergency department
- electronic health record
- papillary thyroid
- weight gain
- squamous cell carcinoma
- body mass index
- bone loss
- physical activity
- human immunodeficiency virus
- systemic sclerosis
- young adults
- genome wide identification
- hiv aids
- transcription factor
- hiv infected
- pulmonary tuberculosis
- data analysis
- body composition
- antiretroviral therapy